This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. [provided by RefSeq, Jul 2008].
Sinha, P K: "Enhanced Induction of Apoptosis in HaCaT Cells by Luteolin Encapsulated in PEGylated Liposomes-Role of Caspase-3/Caspase-14." in: Applied biochemistry and biotechnology, Vol. 188, Issue 1, pp. 147-164, (2019) (PubMed).
George, Kumar, Suresh, Kumar: "Luteolin induces caspase-14-mediated terminal differentiation in human epidermal keratinocytes." in: In vitro cellular & developmental biology. Animal, Vol. 51, Issue 10, pp. 1072-6, (2015) (PubMed).
Jung, Choi, Lee, Kim, Hwang, Choi: "Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis." in: Journal of dermatological science, Vol. 76, Issue 3, pp. 231-9, (2014) (PubMed).